She attained her PhD in Mainz Germany in 2017 where she was understanding the genomics of multidrug resistance in a broad spectrum of cancer cells. The role of P-glycoprotein was key to this understanding. This was then followed by a postdoctoral experience at the National Institute of Health, National Cancer Institute, Bethesda Maryland, USA where she worked on the CRISPAR techniques in understanding multidrug resistance genomics in ovarian, uterine and Breast cancer. She is currently at Early research fellow working on antimicrobial resistance (AMR) in Kilifi Kenya where she is focusing on bacterial genomics and the role of the microbiome in carriage of ESBL-Es. To this point the gruop focusses on community acquired and carriage of ESBL-E and as of now are on the early phases of the research.